Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Cellectar Biosciences, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
National Cancer Institute (NCI)
University of Virginia
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Washington University School of Medicine
Children's Oncology Group
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
Vanderbilt University
Children's Oncology Group
INSYS Therapeutics Inc
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Neotropix